MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Phibro Animal Health Corp

Geschlossen

BrancheGesundheitswesen

17.94 4.24

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

16.91

Max

18

Schlüsselkennzahlen

By Trading Economics

Einkommen

-3.8M

3.2M

Verkäufe

49M

309M

KGV

Branchendurchschnitt

34.438

57.333

EPS

0.54

Dividendenrendite

2.78

Gewinnspanne

1.03

Angestellte

1,940

EBITDA

-4.9M

26M

Empfehlungen

By TipRanks

Empfehlungen

Sell

12-Monats-Prognose

+23.55% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.78%

2.63%

Nächstes Ergebnis

7. Mai 2025

Nächste Dividendenausschüttung

25. Juni 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

670M

Vorheriger Eröffnungskurs

13.7

Vorheriger Schlusskurs

17.94

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

Phibro Animal Health Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

29. Apr. 2024, 10:57 UTC

Akquisitionen, Fusionen, Übernahmen

Zoetis to Sell Medicated-Feed-Additive Portfolio to Phibro for $350 Million

Peer-Vergleich

Kursveränderung

Phibro Animal Health Corp Prognose

Kursziel

By TipRanks

23.55% Vorteil

12-Monats-Prognose

Durchschnitt 21.25 USD  23.55%

Hoch 25 USD

Tief 18 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Phibro Animal Health Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Sell

4 ratings

0

Buy

2

Halten

2

Sell

Technischer Score

By Trading Central

14.2 / 15.6Unterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

Strong Bearish Evidence

Langfristig

Strong Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.